GlassScriptPhysician profile
Matthew Thomas Priest
NPI 1447711874
$599.40
in general payments reported to CMS, 2019-2025
18 companies · $154 in 2025
The $154 reported for 2025 was more than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $87.20 · 2022: $30.41 · 2023: $55.55 · 2024: $272 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $481.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $79.37 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $78.07 | 2025 | Qelbree |
| Teva Pharmaceuticals USA, INC. | $46.41 | 2023-2024 | Ajovy, Austedo |
| Boston Scientific Corporation | $42.01 | 2024 | |
| Lilly USA, LLC | $41.53 | 2022-2025 | Mounjaro |
| Amgen INC. | $33.57 | 2021 | |
| Astellas Pharma US INC | $32.43 | 2024 | Veozah |
| Solventum Corporation | $30.44 | 2025 | 3m Cavilon, Promogran Prisma, 3m Coban |
| Biohaven Pharmaceuticals, INC. | $29.98 | 2021 | |
| Exact Sciences Corporation | $24.48 | 2024 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $24.19 | 2023 | Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $23.65 | 2021 | |
| Inari Medical, INC. | $22.71 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Dexcom, INC. | $21.71 | 2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $21.14 | 2024 | Ozempic, Rybelsus |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $18.27 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.83 | 2025 | Trintellix |
| Janssen Pharmaceuticals, INC | $14.61 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Priest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.